Related Experiment Video
Updated: Sep 25, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer
Shih Yu Cindy Yang1, Trevor J Pugh1,2,3, Amit M Oza1,4,5
1Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Abstract:
Dramatic differences in outcome between early- and late-stage high-grade serous ovarian cancer (HGSC) suggest perhaps distinct genetic origins due to differences in exposures to mutational processes. Evidence to support this hypothesis was recently reported by comparative analysis of copy-number signatures between early- and late-stage HGSCs. See related article by Cheng et al., p. 2911.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Oogenesis
Ovarian Cycle

